QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars

About this update from Qiagen N.v.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":242,"height":204,"url":"https://media.zenfs.com/en/business-wire.com/f11a2ee24505f1fb2764229cb5e24376"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/V6y4WgPAze_prjXW8vfXNA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM1NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/f11a2ee24505f1fb2764229cb5e24376","width":242,"height":204}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Q4 2025: Net sales of $540 million (+4% at actual rates, +1% at constant exchange rates (CER)); diluted EPS of $0.49 and adjusted diluted EPS of $0.62","length":150,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Net sales growth of 1% CER ahead of outlook for steady results vs. Q4 2024, adjusted diluted EPS of $0.62 CER ahead of outlook of about $0.60 CER","length":145,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":145,"olType":false}]},{"val":[{"type":"text","content":"FY 2025: Net sales of $2.09 billion (+6% at actual rates, +5% CER) at high end of outlook for 4-5% CER growth, adj. diluted EPS of $2.40 CER ahead of outlook of about $2.38 CER","length":176,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Growth pillars on target and deliver $1.49 billion CER of sales with 8% CER growth","length":82,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adjusted operating income margin at 29.5%, rises 80 basis points from 2024 despite tariffs and currency headwinds","length":113,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":195,"olType":false}]},{"val":[{"type":"text","content":"2026 outlook: Net sales growth of at least 5% CER with growth pillars expected to contribute about $1.64 billion CER (~+9% CER) and adj. diluted EPS of at least $2.50 CER","length":170,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":836,"olType":false},{"type":"text","content":"VENLO, Netherlands, February 04, 2026--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the fourth quarter and full-year 2025.","length":178,"tagName":"p"},{"type":"text","content":"Net sales for Q4 2025 rose 4% to $540 million, with sa...

More updates from Qiagen N.v.